13th October 2021 | Pharma Updates

Merck's Covid Drug looks India's Everest Organics hit start on production

Everest Organics has started production of Merck’s Covid drug just as the pharma company filed for EUA from the US FDA for the treatment.

Supreem Pharma presenting Consumer Div

Supreem Pharma has launched the consumer division for manufacturing specialty products.

Acute Therapy forwards Drug Sector Growth In September

India’s pharma market grew last month, driven by sales in drugs illnesses such as cough, respiratory diseases and cold, as
more people started going outside.

Biological E seeks India's drug regulator approval for phase-3 trial of Corbevax as booster shot

The drug firm has sought the nod of the Drugs Controller General of India to conduct the phase-3 clinical study of Corbevax as a single booster shot.

Govt wants to set up 10000 Janaushadhi Kendras by 2024

The Indian Government wants to increase the number of Janaushadhi Kendras across the country by March 2024.

Vifor Pharma declares changes to its Executive Committee

Executive committee members Lee Heeson and Gregory Oakes to leave the company due to personal reasons.

IIM Indore inks Letter of Intent with AstraZeneca

Indian Institute of Management Indore has signed a Letter of Intent with AstraZeneca India for the expansion of healthcare delivery services through a partnership.